NCT01702415View on ClinicalTrials.gov

Zoledronic Acid in Cystic Fibrosis

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Cystic Fibrosis

Interventions

DRUG

Zoledronic acid

Single dose, intravenous solution 5mg

DRUG

Placebo

Trial Locations (1)

CB23 3RE

Papworth Hospital NHS Foundation Trust, Cambridge

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV